☆ 4.7 Editorial Material

Lack of Clinical Benefit of Interferon β-1a Among Patients With Severe Acute Respiratory Distress Syndrome Time to Overhaul Drug Trials in ARDS?

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Get Full Text
Add to Collection

Journal

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Volume 323, Issue 8, Pages 713-715

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/jama.2019.22524

Keywords

-

Categories

Medicine, General & Internal

Funding

  1. National Institute for Health Research Clinician Scientist Award [CS-2016-16-011]
  2. NIH [HL140026]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.